Metastatic colorectal cancer

1 paper

Trial sponsors

Merck KGaA
Company1 trialPhase 3553 people
AB Science
Company1 trialPhase 3123 people
Bayer
Company1 trialPhase 2198 people
Genentech
Company1 trialPhase 2127 people
Karyopharm Therapeutics
Company1 trialPhase 1/2277 people
Erasca
Company1 trialPhase 1/2101 people
mAbxience Research
Company1 trialPhase 1142 people
Hutchmed
Company1 trialPhase 132 people

Latest

4 in 12 months

JMIR Research Protocols7 h

Geriatric Assessment-Based Stratification to Evaluate Treatment Intensity, Quality of Life, and Survival in Older Patients With Metastatic Colorectal Cancer: Protocol for a Prospective Observational Study

Study protocolBiomarkers

European Journal of Surgical Oncology18 Sep

Spotting the vulnerable: Preoperative risk stratification in non-metastatic colorectal cancer patients aged 80 years and older

Cohort study of 449 peopleColorectal cancer

European Journal of Surgical Oncology17 Sep

Long-term quality of life and physical functioning after curative local treatment of colorectal metastases in older patients

Cohort study of 122 peopleInterventions

Research Square30 Aug

Protective Effect of Oral Antidiabetic Medicines Against Mechanical Ileus Development and Its Impact on Metastatic Colon Cancer Survival

Preprint: cohort study of 244 peopleColon cancer